{"id":"W4390106584","doi":"10.5489/cuaj.8537","title":"Addressing controversial areas in the management of advanced prostate cancer in Canada","year":2023,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Vancouver General Hospital; University of Calgary; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto; Western University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Jewish General Hospital; Kingston Health Sciences Centre; McGill University; University of Ottawa; Ottawa Hospital; BC Cancer Agency; McMaster University; St. Joseph’s Healthcare Hamilton; Juravinski Cancer Centre; University of British Columbia; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"Ipsen; Sun Pharma; Seagen; EMD Serono; Bavarian Nordic; Eisai; Daiichi Sankyo Europe; Sanofi; AstraZeneca; Amgen; Pfizer; Astellas Pharma; F. Hoffmann-La Roche","keywords":"Prostate cancer; Medicine; Consensus conference; Management of prostate cancer; Family medicine; Gynecology; Oncology; Cancer; Medical physics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03506005,0.0007096363,0.0006898574,0.003305202,0.01622926,0.005080066,0.004398887,0.007817364,0.00692257],"category_scores_gemma":[0.05062117,0.0007090056,0.001380522,0.00353008,0.005427167,0.001878022,0.006321516,0.005957137,0.0006386081],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.144734,"about_ca_system_score_gemma":0.4402557,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9170542,"about_ca_topic_score_gemma":0.9581434,"domain_scores_codex":[0.9648755,0.008392548,0.002549415,0.001948603,0.01497049,0.007263485],"domain_scores_gemma":[0.8976774,0.01154421,0.004665268,0.0007380891,0.05488928,0.03048569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001745971,0.0001311718,0.03005622,0.00276062,0.0001194331,0.001542543,0.01283022,0.00155502,0.001908247,0.01199507,0.7696325,0.1672943],"study_design_scores_gemma":[0.0001405931,0.0001220365,0.04874876,0.0040817,0.00006938095,0.0006725578,0.01690342,0.0009711779,0.0007414212,0.007466307,0.9198245,0.0002580349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.03309461,0.03349707,0.003683376,0.8614098,0.009572867,0.001365131,0.001630604,0.0001319633,0.05561455],"genre_scores_gemma":[0.5920573,0.03471151,0.03003269,0.2859874,0.005050571,0.001325215,0.003587965,0.0002514297,0.04699593],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.144734,"threshold_uncertainty_score":0.9919873,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02977685283423935,"score_gpt":0.3020860880220539,"score_spread":0.2723092351878146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}